ATA505279A - Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung - Google Patents

Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung

Info

Publication number
ATA505279A
ATA505279A AT0505279A AT505279A ATA505279A AT A505279 A ATA505279 A AT A505279A AT 0505279 A AT0505279 A AT 0505279A AT 505279 A AT505279 A AT 505279A AT A505279 A ATA505279 A AT A505279A
Authority
AT
Austria
Prior art keywords
solns
soln
prodn
immunoglobulin
degrees
Prior art date
Application number
AT0505279A
Other languages
English (en)
Other versions
AT368886B (de
Inventor
Karl Dr Buennig
Original Assignee
Blutspendedienst Dt Rote Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Dt Rote Kreuz filed Critical Blutspendedienst Dt Rote Kreuz
Publication of ATA505279A publication Critical patent/ATA505279A/de
Application granted granted Critical
Publication of AT368886B publication Critical patent/AT368886B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT0505279A 1978-08-25 1979-07-23 Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung AT368886B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782837168 DE2837168A1 (de) 1978-08-25 1978-08-25 Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung

Publications (2)

Publication Number Publication Date
ATA505279A true ATA505279A (de) 1982-04-15
AT368886B AT368886B (de) 1982-11-25

Family

ID=6047909

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0505279A AT368886B (de) 1978-08-25 1979-07-23 Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung

Country Status (7)

Country Link
US (1) US4322403A (de)
JP (1) JPS5547627A (de)
AT (1) AT368886B (de)
DE (1) DE2837168A1 (de)
FR (1) FR2433946A1 (de)
GB (1) GB2032437B (de)
SE (1) SE7906272L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
DE3310150A1 (de) * 1983-03-21 1984-09-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
EP0973384A4 (de) * 1997-02-13 2004-10-13 Sky High Llc Organkonservierungslösung
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
EP3673919A1 (de) 2005-06-14 2020-07-01 Amgen Inc. Selbstpuffernde proteinformulierungen
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US20100278935A1 (en) * 2007-07-30 2010-11-04 Stacey William C Immune System Modulator Formulation
JP6884858B2 (ja) 2016-10-21 2021-06-09 アムジエン・インコーポレーテツド 医薬製剤及びその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6702923A (de) * 1966-04-06 1967-10-09
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
DE1792555C3 (de) * 1968-09-19 1980-01-10 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung einer für die intravenöse Anwendung geeigneten Gammaglobulinlösung
IL34079A (en) * 1969-04-01 1973-02-28 Upjohn Co Purification of ypsilon-globulins
US3607857A (en) * 1970-03-03 1971-09-21 Upjohn Co Process of removing acrinol from gamma globulin using siliceous material such as silica gel
FR2267115B1 (de) * 1974-04-12 1977-11-10 Merieux Inst
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin

Also Published As

Publication number Publication date
SE7906272L (sv) 1980-02-26
AT368886B (de) 1982-11-25
GB2032437A (en) 1980-05-08
FR2433946A1 (fr) 1980-03-21
DE2837168A1 (de) 1980-03-06
JPS5547627A (en) 1980-04-04
US4322403A (en) 1982-03-30
GB2032437B (en) 1982-10-27

Similar Documents

Publication Publication Date Title
ATA505279A (de) Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung
CA2123811A1 (en) Type i and type ii surface antigens associated with staphylococcus epidermidis
ATE182359T1 (de) Nichtreduzierendes saccharidbildendes enzym, und dessen herstellung und verwendungen
IE810697L (en) Preparation of cephalosporin derivatives and intermediates¹therefor
GB1528316A (en) Purifying xanthan gum
NO844628L (no) Fremgangsmaate for fremstilling av oligosakkaridholdige produkter
ATE158184T1 (de) Herstellung und verwendung von transfer-faktor
AU7370491A (en) 2,8-dioxabicyclo(3,2,1)octane derivatives,their production from cultures of MF 5447 and MF 5466 and their use as anti hyper cholesterolemics
Alam et al. The purification, properties and characterization of three forms of α-l-fucosidase from monkey brain
SE8005399L (sv) Framstellning av sampolymerer av propen och but-1-en
DE69220571D1 (de) Verfahren zur herstellung von pvp-h202-produkten
FR2342733A1 (fr) Derives de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
IE840694L (en) Process for the isolation of tylosin
FR2610633B1 (fr) Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament
CA2046128A1 (en) Method of purifying ferment-produced riboflavin
EP0441395A3 (en) Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infections
IE35686B1 (en) Process for purifying lactams
FR2340093A1 (fr) Derives de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
CA2073351A1 (en) Lysozyme dimers and method of preparing them
DE2962521D1 (en) Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby
ATE78257T1 (de) Im wesentlichen wasserfreies kristallines cefadroxil und verfahren zu dessen herstellung.
AU541532B2 (en) Purify starting materials in making amphotensides
CA2062105A1 (en) Purified mite allergen
Chibata et al. [21] Coenzyme A
AU523983B2 (en) Process to increase the molecular weight of silicon compounds

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee